Link to this page

Your search term(s) "diabetes prevention program" returned 15 results.

Displaying all search results.

Diabetes Overview. Bethesda, MD: National Diabetes Information Clearinghouse. 2008. 16 p.

This fact sheet provides an overview of information about diabetes, defined as a disorder of metabolism. The fact sheet describes the three main types of diabetes: type 1 diabetes, an autoimmune disease in which the pancreas produces little or no insulin; type 2 diabetes, in which the body does not produce enough insulin or uses insulin inefficiently; and gestational diabetes, which is associated with pregnancy and a subsequent increased risk for type 2 diabetes. The fact sheet discusses diagnostic considerations, the condition of pre-diabetes, the complications that may be associated with diabetes, epidemiology of type 1 and type 2 diabetes, and patient care for people with diabetes. The fact sheet describes current research efforts in the diabetes arena, including the Diabetes Prevention Trial–Type 1 (DPT-1), the Environmental Determinants of Diabetes in the Young Consortium (TEDDY), Type 1 Diabetes TrialNet, the Immune Tolerance Network, the Trial to Reduce IDDM in the Genetically at Risk (TRIGR), islet transplantation studies, the Diabetes Prevention Program (DPP), studies on type 2 diabetes in children and teens, and studies focusing on preventing and treating cardiovascular disease in people with type 2 diabetes. Contact information for three resource organizations is listed: the American Diabetes Association at www.diabetes.org or 1–800–342–2383, the National Diabetes Education Program at www.ndep.nih.gov or 1–888–693–6337, and the Juvenile Diabetes Research Foundation International at ww.jdrf.org or 1–800–533–2873. A final section provides contact information and a brief description of the goals and activities of the National Diabetes Information Clearinghouse (NDIC), a Government service that provides information about diabetes to people with diabetes and to their families, health care professionals, and the public. 1 figure.

Full Record   Printer Friendly Version

Providing Long-Term Support for Lifestyle Changes: A Key to Success in Diabetes Prevention. Diabetes Spectrum. 20(4): 205-209. Fall 2007.

This article is one from a series on the importance of diabetes self-management education (DSME) in the everyday care of people with diabetes and in prevention of the complications of the disease. The authors remind readers that there is increasing evidence to demonstrate that type 2 diabetes can be delayed or prevented in people with elevated risk by modest changes in lifestyle. The authors explore how partnering with the YMCA organization can result in a community-based intervention approach to implement diabetes prevention programs. YMCA staff trained to deliver a structured lifestyle intervention to prevent diabetes can achieve short-term weight-loss results comparable to those achieved during the Diabetes Prevention Program clinical trial. The authors comment on the importance of maintaining intervention programs to maintain the benefits they [s2]can achieve. 42 references.

Full Record   Printer Friendly Version

Diabetes Overview. Bethesda, MD: National Diabetes Information Clearinghouse. 2006. 16 p.

This fact sheet provides an overview of information about diabetes, defined as a disorder of metabolism. The fact sheet describes the three main types of diabetes: type 1 diabetes, an autoimmune disease in which the pancreas produces little or no insulin; type 2 diabetes, in which the body does not produce enough insulin or uses insulin inefficiently; and gestational diabetes, which is associated with pregnancy and an increased risk of type 2 diabetes subsequently. The fact sheet then discusses diagnostic considerations, the condition of pre-diabetes, the complications that may be associated with diabetes, epidemiology of type 1 and type 2 diabetes, and patient care for people with diabetes. The fact sheet also describes current research efforts in the diabetes arena, including the Environmental Determinants of Diabetes in the Young Consortium (TEDDY), Type 1 Diabetes TrialNet, the Immune Tolerance Network, islet transplantation studies, the Diabetes Prevention Program (DPP), studies on type 2 diabetes in children and teens, and studies focusing on preventing and treating cardiovascular disease in people with type 2 diabetes. The contact information for four resource organizations is listed. A final section provides the contact information and a brief description of the goals and activities of the National Diabetes Information Clearinghouse. 2 figures.

Full Record   Printer Friendly Version

Lifestyle for Prevention: Choices, Changes, Challenges. IN: Mensing, C., ed. Art and Science of Diabetes Self-Management Education. Chicago, IL: American Association of Diabetes Educators. pp. 22-42.

This chapter on lifestyle for the prevention of diabetes is from a comprehensive text that serves as a resource for all health professionals, community professionals, and individuals who provide education to individuals with diabetes. The authors note that the prevention and delay of diabetes and the chronic complications associated with diabetes have become urgently important in both public health and patient care. Education plays a large role in preventing and delaying the onset of type 2 diabetes, as well as in preventing and controlling its devastating complications. Topics covered include risk factors and their interactions, the effectiveness of lifestyle intervention in diabetes prevention, related landmark studies including the Diabetes Prevention Program (DPP), self-care behaviors, translating prevention research for diverse populations and settings, a clinical approach for high-risk individuals, the Medicare Medical Nutrition Therapy Act of 2005, and the role of a community approach to diabetes prevention. The chapter includes a list of key points, a summary of teaching strategies, suggested Internet resources, a glossary of key terms, and a list of references. 1 figure. 4 tables. 44 references.

Full Record   Printer Friendly Version

Your Game Plan to Prevent Type 2 Diabetes. Information for Patients. Bethesda, MD: National Diabetes Education Program. 2006. 20 p.

This booklet offers information about diabetes prevention for people at high risk for developing diabetes. The two main keys to success are getting at least 30 minutes of moderate-intensity physical activity five days a week, and eat a variety of foods that are low in fat and reduce the number of calories eaten each day. The booklet presents a "Game Plan" which is based on the Diabetes Prevention Program (DPP) research study that showed that type 2 diabetes could be prevented or delayed in people with increased risk by losing a small amount of weight and getting 30 minutes of moderate-intensity physical activity. This booklet is designed to help readers take steps to prevent diabetes, set goals, and track their progress. The chapters of the booklet cover the risk factors for type 2 diabetes and pre-diabetes, small steps for eating healthy foods, and small steps for getting more physical activity. The booklet also includes food and activity tracker pages for photocopying and a list of additional resources, with their telephone numbers and web site addresses. The booklet is illustrated with photographs of people living an active lifestyle. 2 figures. 5 tables.

Full Record   Printer Friendly Version

Your Game Plan to Prevent Type 2 Diabetes. Information for Patients. Bethesda, MD: National Diabetes Education Program. 2006. 20 p.

This booklet provides fat and calorie content information to help people following a "Game Plan" for diabetes prevention. The "Game Plan" is based on the Diabetes Prevention Program (DPP) research study that showed that type 2 diabetes could be prevented or delayed in people with increased risk by losing a small amount of weight and getting 30 minutes of moderate-intensity physical activity. This booklet lists foods alphabetically, with the serving size, number of fat grams, and calories noted for each item. The back cover has the contact information for the National Diabetes Education Program (NDEP).

Full Record   Printer Friendly Version

Clinical Outcomes and Cost-Effectiveness of Strategies for Managing People at High Risk for Diabetes. Annals of Internal Medicine. 143(4): 251-264, W53-W68. August 2005.

Lifestyle modification can forestall diabetes in high-risk people, but the long-term cost-effectiveness is uncertain. This article reports on a study undertaken to estimate the effects of the lifestyle modification program used in the Diabetes Prevention Program (DPP) on health and economic outcomes. The authors performed a cost-effectiveness analysis using the Archimedes model. Results showed that, compared with no prevention program, the DPP lifestyle program would reduce a high-risk person's 30-year chances of getting diabetes from about 72 percent to 61 percent, the chances of a serious complication from about 38 percent to 30 percent, and the chances of dying of a complication of diabetes from about 13.5 percent to 11.2 percent. The drug metformin would deliver about one-third of the long-term health benefits achievable by immediate lifestyle modification. Compared with not implementing any prevention program, the expected 30-year cost per quality-adjusted life-year (QALY) of the DPP lifestyle intervention from the health plan's perspective would be about $143,00. From a societal perspective, the cost per QALY of the lifestyle intervention (compared with doing nothing) would be about $62,600. Either using metformin of delaying the lifestyle intervention until after a person develops diabetes would be more cost-effective, costing about $35,400 or $24,500 per QALY gained, respectively, compared with no program. Compared with delaying the lifestyle program until after diabetes is diagnosed, the marginal cost-effectiveness of beginning the DPP lifestyle program immediately would be about $201,800. Compared with no program, lifestyle modification for high-risk people can be made cost-saving over 30 years if the annual cost of the intervention can be reduced to about $100. The authors conclude that lifestyle modification is likely to have important effects on the morbidity and mortality of diabetes and should be recommended to all high-risk people. However, the program used in the DPP study may be too expensive for health plans or a national program to implement. The authors call for less expensive methods to achieve the degree of weight loss seen in the DPP. A lengthy appendix is included that contains additional information about the Archimedes model pertinent to the analysis of the prevention and management of diabetes in high-risk people. 10 figures. 10 tables. 48 references.

Full Record   Printer Friendly Version

Cost-Effectiveness of Lifestyle Modification or Metformin in Preventing Type 2 Diabetes in Adults with Impaired Glucose Tolerance. Annals of Internal Medicine. 142(5): 323-332. March 2005.

The Diabetes Prevention Program (DPP) demonstrated that interventions can delay or prevent the development of type 2 diabetes. This article reports on a study undertaken to estimate the lifetime cost-utility of the DPP interventions. The authors use a Markov simulation model to estimate progression of disease, costs, and quality of life. The interventions considered include intensive lifestyle, metformin, and placebo. The results showed that, compared with the placebo intervention, the lifestyle and metformin interventions were estimated to delay the development of type 2 diabetes by 11 years and 3 years, respectively, and to reduce the absolute incidence of diabetes by 20 percent and 8 percent, respectively. The cumulative incidence of complications were reduced and survival was improved by 0.5 years and 0.2 years. Compared with the placebo intervention, the cost per quality adjust life-years (QALY) was approximately $1100 for the lifestyle intervention and $31,300 for the metformin intervention. From a societal perspective, the interventions cost approximately $8,800 and $29,900 per QALY, respectively. From both perspectives, the lifestyle intervention outperformed the metformin intervention. The authors caution that simulation results depend on the accuracy of the underlying assumptions, including participant adherence.

Full Record   Printer Friendly Version

Depression Symptoms and Antidepressant Medicine Use in Diabetes Prevention Program Participants. Diabetes Care. 28(4): 830-837. April 2005.

This article reports on a study that assessed depression markers (symptoms and antidepressant medicine use) in Diabetes Prevention Program (DPP) participants and determined whether changes in depression markers during the course of the study were associated with treatment arm, weight change, physical activity level, or participant demographic characteristics. The DPP participants (n = 3,187) were in one of three treatment arms: intensive lifestyle, metformin, and placebo. On study entry, 10.3 percent of participants had Beck Depression Inventory (BDI) scores greater than 11, which was used as the threshold for mild depression; 5.7 percent took antidepressant medicines, and 0.9 percent had both depression markers (BDI score over 11 and antidepressant medications). During the DPP, the proportion of participants with elevated BDI scores declined, while the proportion taking antidepressant medicines increased, leaving the proportion with either marker unchanged. These time trends were not significantly associated with the DPP treatment arm. Men were less likely to have elevated depression scores and were less likely to use antidepressant medicine at baseline. Those with more education were less likely to have elevated symptoms scores but more likely to be taking antidepressant medicine. Non-Hispanic white participants were less likely than African Americans to have BDI scores greater than 11, but white participants were most likely to be taking antidepressant medicine than any other racial/ethnic group. The authors conclude that the finding that those taking antidepressant medicine often do not have elevated depression symptoms indicates the value of assessing both markers when estimating overall depression rates. 2 figures. 2 tables. 44 references.

Full Record   Printer Friendly Version

Fishes, Whales, and Fishing Tips: Hooking an Active Lifestyle. Diabetes Spectrum. 18(2): 114-118. Spring 2005.

Given that a physically active lifestyle is important to health and quality of life, health care professionals are faced with the challenge of guiding individuals as they attempt to increase their level of physical activity. This article shares the suggestions of several lifestyle interventionists (many of whom were part of the Diabetes Prevention Program) gleaned from their experiences with participants and patients whom they have encountered through the years. The authors first review the benefits of an active lifestyle for people with diabetes, then discuss the problem of many people who continue to choose a sedentary lifestyle. Other topics covered include public health recommendations, the Diabetes Prevention Program (DPP) and its findings, the importance of maintaining any exercise or activity program, the fun of exercising with friends, creative ways to incorporate exercise and activity into everyday life, and how to handle and overcome barriers to exercise. 13 references.

Full Record   Printer Friendly Version

I Can Lower My Risk for Type 2 Diabetes: A Guide for American Indians. Bethesda, MD: National Diabetes Information Clearinghouse, 2005. 16 p.

Although people with diabetes can prevent or delay complications by keeping blood glucose levels close to normal, preventing or delaying the development of type 2 diabetes in the first place is even better. This booklet, written in nontechnical language, answers common questions about type 2 diabetes and its prevention and management. The booklet begins with a letter from a Native American physician and a note that describes the results of the Diabetes Prevention Program, which demonstrated successful strategies for preventing diabetes in people at high risk for the condition. Topics include the different types of diabetes, the signs and symptoms of type 2 diabetes, the condition pre-diabetes, risk factors for type 2 diabetes, how to know if one should be tested for diabetes, and how to lower the risks for diabetes. Another section describes research that focused on a population of Pima Indian volunteers. Two forms are included for readers to keep track of their daily food and drink intake and their daily physical activities. A final section summarizes the activities of the National Diabetes Information Clearinghouse. 3 figures. 5 tables.

Full Record   Printer Friendly Version

Sailing on a Wave of New Research: Part 2. Diabetes Forecast. 58(11): 45-48. November 2005.

This article, the second in a two-part series, summarizes recent research findings that were reported at the American Diabetes Association's 65th Scientific Sessions, held in San Diego (2005). This article covers undiagnosed kidney disease in people with type 2 diabetes, diet soda and weight gain in both type 1 and type 2 diabetes, poor diabetes control and depression in children and adolescents with type 1 diabetes, the use of exercise to prevent gestational diabetes, and eye disease (retinopathy) that may develop before clinical diabetes develops. Some of the information reported is from the Diabetes Prevention Program (DPP), a study that showed that weight loss, exercise, or treatment with the diabetes drug metformin can cut the risk of developing diabetes in people with pre-diabetes.

Full Record   Printer Friendly Version

Strategies to Identify Adults at High Risk for Type 2 Diabetes: The Diabetes Prevention Program. Diabetes Care. 28(1): 138-144. January 2005.

The Diabetes Prevention Program (DPP) was a large, multicenter, randomized clinical trial testing interventions to prevent or delay type 2 diabetes. A major challenge of the program was to identify eligible high-risk adults, defined by DPP as having both impaired glucose tolerance (IGT) (2-hour glucose 140-199 milligrams per deciliter) and elevated fasting plasma glucose (EFG, defined as 95-125 mg/dl). This article reports on these strategies used to identify adults at high risk for type 2 diabetes. The study analyzed how screening yields would be affected by the presence of established risk factors such as age, sex, ethnicity, BMI, and family history of diabetes, and how much yields would be enhanced by preselecting individuals with elevated capillary blood glucose. Of 158,177 adults originally contacted, 79,190 were potentially eligible. The authors report on the 30,383 participants who completed an oral glucose tolerance test (OGTT). Based on the OGTT, 27 percent had impaired glucose tolerance with EFG, meeting the DPP eligibility criteria for being at high risk of diabetes, and 13 percent had previously-undiagnosed diabetes (based on OGTT). The authors conclude that the DPP screening approach successfully identified adults with or at high risk for type 2 diabetes across various ethnic groups and provided guidance to more efficient use of OGTTs. They note that fasting capillary glucose is a useful adjunct in screening programs combined with data on age and adiposity. 3 figures. 2 tables. 21 references.

Full Record   Printer Friendly Version

Effects of Glycemic Control on Diabetes Complications and on the Prevention of Diabetes. Clinical Diabetes. 22(4): 162-165. Fall 2004.

This article reviews randomized, controlled clinical trials (RCT's) completed during the past several years or currently underway that have addressed glycemic control. Landmark RCTs have demonstrated that meticulous glycemic (blood glucose) control reduces the risk of microvascular (small blood vessel) and neurological (nerve) complications of diabetes. Studies in pre-diabetes have shown that early intervention slows progression to diabetes. Ongoing studies are examining the effects of glycemic interventions on macrovascular complications of diabetes, the impact of early treatment on the course of diabetes, and whether there are differences depending on the type of the intervention used, including aggressive control of blood pressure and normalization of lipids (fats). Some of the studies discussed include the Diabetes Control and Complications Trial (DCCT), the U.K. Prospective Diabetes Study (UKPDS), the Stockholm Diabetes Intervention Study (SDIS), the Veterans Affairs Diabetes Trial (VADT), the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial, the U.S. Diabetes Prevention Program (DPP), the Heart Outcomes Prevention Evaluation (HOPE) trial, the Losartan Intervention for Endpoint Reduction in Hypertension (LIFE) study, the Diabetes Reduction Assessment with Ramipril and Rosiglitazone Medication (DREAM) study, the Nateglinide and Valsartan in Impaired Glucose Tolerance Outcomes Research (NAVIGATOR) trial, Actos Now for Prevention of Diabetes (ACT-NOW), the Outcome Reduction with an Initial Glargine Intervention (ORIGIN), A Diabetes Outcome Progression Trial (ADOPT), and the Rosiglitazone Evaluated for Cardiac Outcomes and Regulation of Glycemia in Diabetes (RECORD) study. 2 tables. 32 references.

Full Record   Printer Friendly Version

Translating the Diabetes Prevention Program. IN: From Clinical Trials to Community: The Science of Translating Diabetes and Obesity Research. Bethesda, MD: National Diabetes Information Clearinghouse. pp. 49-52.

This document was prepared to assist investigators in either academic or community-based organizations who are engaged in translational activities or translational research. The document reports the proceedings of a conference sponsored by the Diabetes Mellitus Interagency Coordinating Committee (DMICC) in January 2004 in Bethesda, MD, on the subject of diabetes translation, a focus that underpins bringing the results of laboratory discoveries and clinical research to the patient and to medical practice. This document reviews the findings of the Diabetes Prevention Program (DPP) research and shows how it can be translated to the clinical setting. The DPP demonstrated that type 2 diabetes can be delayed or possibly prevented by lifestyle modification and use of medication. The interventions, however, were not designed in a way that is directly deliverable on a public health scale. The author notes that translation on a public health scale will require increased community awareness of risk factors for diabetes and strategies for reducing them; defining real-world strategies to identify individuals at risk who are likely to benefit most from lifestyle modification; and developing intervention strategies to enhance dissemination and sustainability in nonresearch environments, particularly community venues where it can be accessed by broader segments of the population. 9 references.

Full Record   Printer Friendly Version

Displaying all search results.

Start a new search.